# 10x Genomics (TXG) — News

TXG · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/txg/news

## Recent headlines

- [China Resources Land - Sept 2026 gross contracted sales RMB 15.50 bln](https://www.ainvest.com/news/china-resources-land-sept-2026-gross-contracted-sales-rmb-15-50-bln-2610) — AInvest Wire, Oct 13, 2026
  China Resources Land (SEHK:1109) reported gross contracted sales of RMB 15.50 billion in September 2026, according to recent filings. This figure reflects the company’s ongoing efforts to maintain sales momentum amid a challenging property development environment. The sales performance aligns with…
- [10X Genomics, Inc.: TD Cowen raises target price to $70 from $47](https://www.ainvest.com/news/10x-genomics-td-cowen-raises-target-price-70-47-2610) — AInvest Wire, Oct 13, 2026
- [10x Genomics (TXG) shares rose 6.09% in intraday trading after Bank of America Securities upgraded its price target on the stock to $80 from $50, while maintaining a Hold rating.](https://www.ainvest.com/news/10x-genomics-txg-shares-rose-6-09-intraday-trading-bank-america-securities-upgraded-price-target-stock-80-50-maintaining-hold-rating-2610) — AInvest Wire, Oct 9, 2026
  10x Genomics (TXG) shares rose 6.09% in intraday trading following an upgrade to the stock’s price target by Bank of America Securities. The firm raised its price target to $80 from $50, while maintaining a "Hold" rating on the stock. The adjustment reflects the analyst’s updated assessment of the…
- [10x Genomics (TXG) shares dropped 7.61% intraday on October 7, pressured by rising Treasury yields and weakness in high-valuation tech and healthcare sectors.](https://www.ainvest.com/news/10x-genomics-txg-shares-dropped-7-61-intraday-october-7-pressured-rising-treasury-yields-weakness-high-valuation-tech-healthcare-sectors-2610) — AInvest Wire, Oct 7, 2026
- [10X Genomics announces new collaboration to advance single cell and spatial applications across solid tumors and blood cancers](https://www.ainvest.com/news/10x-genomics-announces-collaboration-advance-single-cell-spatial-applications-solid-tumors-blood-cancers-2610) — AInvest Wire, Oct 7, 2026
  10x Genomics (Nasdaq: TXG) has announced a new collaboration with Lunit, a leading provider of AI-based cancer diagnostics, to integrate AI-enabled pathology analysis with spatial molecular data for oncology clinical research. This partnership aims to enhance the understanding of tumor biology by…

## Similar Stocks

- [PACB](https://www.lighthorse.io/tickers/pacb) — Pacific Biosciences of California, Inc. - Common Stock
- [TWST](https://www.lighthorse.io/tickers/twst) — Twist Bioscience Corporation - Common Stock

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).